Sequence Similarity Clusters for the Entities in PDB 1NGY

Entity #1 | Chains: A
Mature Metal Chelatase Catalytic Antibody, Light chain protein, length: 213 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 4 6 8238
95 % 4 6 8295 Flexibility: Low
Max RMSD: 5.6, Avg RMSD: 2.3
PDBFlex
90 % 356 816 2
70 % 1144 2634 1
50 % 2343 5348 1
40 % 2682 6031 1
30 % 3245 7494 1
Entity #2 | Chains: B
Mature Metal Chelatase Catalytic Antibody, Heavy chain protein, length: 216 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 52586
95 % 4 6 8240 Flexibility: Medium
Max RMSD: 6.9, Avg RMSD: 3.6
PDBFlex
90 % 6 8 7005
70 % 1134 2593 2
50 % 2344 5348 1
40 % 2683 6031 1
30 % 3246 7494 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
21 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
22 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
23 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
24 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
25 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
26 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
27 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
28 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
29 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
30 4XCF 1 L 4E10 Fab light chain 9606
31 4XCF 2 H 4E10 Fab heavy chain 9606
32 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
33 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
34 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
35 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
36 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
37 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
38 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
39 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
40 5X08 1 H Fab 4E10 Heavy chain 9606
41 5X08 2 L Fab 4E10 Light chain 9606
42 4XAW 1 L 4E10 Fab light chain 9606
43 4XAW 2 H 4E10 Fab heavy chain 9606
44 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
45 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
46 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
47 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
48 5UCB 1 H Fab Heavy Chain 9606
49 5UCB 2 L Fab Light Chain 9606
50 2VXV 1 H HUMAN IGG ABT-325 9606
51 2VXV 2 L HUMAN IGG ABT-325 9606
52 4GXV 1 H, I Antibody 1F1, heavy chain 9606
53 4GXV 2 L, M Antibody 1F1, light chain 9606
54 2VXT 1 H MURINE IGG 125-2H 10090
55 2VXT 3 L MURINE IGG 125-2H 10090
56 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
57 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
58 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
59 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
60 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
61 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
62 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
63 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
64 5W24 1 L 5C4 Fab Light Chain 10090
65 5W24 2 H 5C4 Fab Heavy Chain 10090
66 4HPY 1 H CH59 Fab heavy chain 9606
67 4HPY 2 L CH59 Fab light chain 9606
68 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
69 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
70 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
71 4JG1 1 L Fab light chain 9606
72 4JG1 2 H Fab heavy chain 9606
73 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
74 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
75 5VF2 1 A scFv 2D10 10090
76 5I8C 1 A VRC34.01 Fab heavy chain 9606
77 5I8C 2 B VRC34.01 Fab light chain 9606
78 4O5L 1 L Fab F045-092 light chain 9606
79 4O5L 2 H Fab F045-092 heavy chain 9606
80 5MYX 1 A, C Fab c#24 light chain 10090
81 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
82 3IFL 1 L 12A11 FAB antibody light chain 10090
83 3IFL 2 H 12A11 FAB antibody heavy chain 10090
84 5WK2 1 L M116 LIGHT CHAIN 9606
85 5WK2 2 H M116 HEAVY CHAIN FD 9606
86 3PP4 1 H GA101 Fab heavy chain 10090
87 3PP4 2 L GA101 Fab light chain 10090
88 3KDM 1 A, L Immunoglobulin light chain 9606
89 3KDM 2 B, H Immunoglobulin heavy chain 9606
90 5NIV 1 A Light chain of 5D3 Fab 10090
91 5NIV 2 B Heavy chain of 5D3 Fab 10090
92 5N4J 1 L LIGHT CHAIN 9606
93 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
94 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
95 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
96 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
97 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
98 5X4G 1 A 6H8 Fab heavy chain 10090
99 5X4G 2 B 6H8 Fab light chain 10090
100 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
101 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
102 4PTU 1 A Antibody pn132p2C05, light chain 9606
103 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
104 4TPR 1 L If kappa light chain 10090
105 4TPR 2 H Fab heavy chain 10090
106 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
107 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
108 3IFN 1 H 12A11 FAB antibody heavy chain 10090
109 3IFN 2 L 12A11 FAB antibody light chain 10090
110 5U3P 1 H DH511.4 Fab Heavy Chain 9606
111 5U3P 2 L DH511.4 Fab Light Chain 9606
112 6BLA 1 H AMM01 Fab Heavy chain 9606
113 6BLA 2 L AMM01 Fab Light chain 9606
114 4TOY 1 H 35O22 Fab Heavy chain 9606
115 4TOY 2 L 35O22 Fab Light chain 9606
116 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
117 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
118 3NPS 2 B S4 FAB HEAVY CHAIN 9606
119 3NPS 3 C S4 FAB LIGHT CHAIN 9606
120 5I4F 1 A scFv 2D10 10090
121 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
122 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
123 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
124 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
125 5WN9 1 H scFv 2D10 9606
126 4XC3 1 L 4E10 Fab light chain 9606
127 4XC3 2 H 4E10 Fab heavy chain 9606
128 4M5Y 1 H, I Fab 5J8 heavy chain 9606
129 4M5Y 2 L, M Fab 5J8 light chain 9606
130 4TQE 1 L If kappa light chain 10090
131 4TQE 2 H Fab heavy chain 10090
132 5YY4 1 A scFv 4B08 10090
133 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
134 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
135 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
136 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
137 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
138 5VSI 2 L CH1/Ckappa Fab light chain 9606
139 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
140 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
141 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
142 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
143 5JXA 1 H VRC03 Heavy chain 9606
144 5JXA 2 L VRC03 Light chain 9606
145 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
146 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
147 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
148 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
149 3NTC 1 L Fab light chain 10090
150 3NTC 2 H Fab heavy chain 10090
151 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
152 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
153 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
154 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
155 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
156 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
157 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
158 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
159 6BE3 1 H Fab (F598) Heavy Chain 9606
160 6BE3 2 L Fab (F598) Light Chain 9606
161 4NWU 1 H APE1551 Ab Fab heavy chain 9606
162 4NWU 2 L APE1551 Ab Fab light chain 9606
163 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
164 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
165 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
166 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
167 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
168 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
169 5EWI 1 H VRC38.01 Heavy Chain 9606
170 5EWI 2 L VRC38.01 Light Chain 9606
171 5E2W 1 L AT8 LIGHT CHAIN 10090
172 5E2W 2 H AT8 HEAVY CHAIN 10090
173 5MYK 1 A Fab c#17 light chain 10090
174 5MYK 2 B Fab c#17 heavy chain 10090
175 4NZR 1 H PGT135 heavy chain Fab 9606
176 4NZR 2 L PGT135 light chain Fab 9606
177 5MYO 1 A, C Fab c#6 light chain 10090
178 5MYO 2 B, D Fab c#6 heavy chain 10090
179 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
180 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
181 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
182 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
183 5UEL 1 H 354NC102 Fab Heavy Chain 9606
184 5UEL 2 L 354NC102 Fab Light Chain 9606
185 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
186 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
187 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
188 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
189 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
190 5E2V 1 L AT8 LIGHT CHAIN 10090
191 5E2V 2 H AT8 HEAVY CHAIN 10090
192 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
193 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
194 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
195 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
196 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
197 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
198 5JUE 1 L light chain of UIC2 Fab 10090
199 5JUE 2 H heavy chain of UIC2 Fab 10090
200 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
201 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
202 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
203 5JR1 1 H 10E8 heavy chain 9606
204 5JR1 2 L 10E8 mature light chain 9606
205 6CA7 1 L PCT64_13C light chain 9606
206 6CA7 2 H PCT64_13C heavy chain 9606
207 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
208 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
209 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
210 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
211 5OB5 2 H fAb Heavy chain 9606
212 5OB5 3 L fAb Light chain 9606
213 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
214 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
215 5I66 1 A 8B6 antibody, heavy chain 10090
216 5I66 2 B 8B6 antibody, light chain 10090
217 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
218 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
219 6BZY 1 H 22D11 Heavy Chain 10090
220 6BZY 2 L 22D11 Light Chain 10090
221 3QQ9 1 C, L 101F LIGHT CHAIN 10090
222 3QQ9 2 D, H 101F HEAVY CHAIN 10090
223 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
224 5TKK 3 L mouse antibody vFP5.01 light chain 10090
225 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
226 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
227 5W6C 1 H UCA Fab heavy chain 9606
228 5W6C 2 L UCA Fab light chain 9606
229 5I1K 1 L FAB LIGHT CHAIN 9606
230 5I1K 2 H FAB HEAVY CHAIN 9606
231 3OZ9 1 L Fab NC-1 kappa light chain 10090
232 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
233 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
234 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
235 5V7U 1 L CBTAU-22.1 Fab light chain 9606
236 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
237 5UEA 1 A, H Fab Heavy Chain 9606
238 5UEA 3 B, L Fab Light Chain 9606
239 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
240 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
241 3G5Y 1 A 175 light chain 10090
242 3G5Y 2 B 175 heavy chain 10090
243 5NMV 1 L Fab light chain 10088
244 5NMV 2 H Fab heavy chain 10088
245 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
246 4N8C 2 L, M Light chain of monoclonal antibody 10090
247 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
248 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
249 4HGW 1 A Antibody Fab fragment, light chain 10090
250 4HGW 2 B Antibody Fab fragment, heavy chain 10090
251 1NLB 1 L antibody 19D9D6 light chain 10090
252 1NLB 2 H antibody 19D9D6 heavy chain 10090
253 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
254 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
255 3VFG 1 L 3F8 Light Chain 10090
256 3VFG 2 H 3F8 Heavy Chain 10090
257 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
258 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
259 3QRG 1 L Fab light chain 9606
260 3QRG 2 H Fab heavy chain Fd fragment 9606
261 5M6A 1 A, B, C, D Bence-Jones light chain 9606
262 4LLY 2 B, D light chain Clambda 9606
263 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
264 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
265 5EZI 1 H Fab c12 heavy chain 9606
266 5EZI 2 L Fab c12 Light chain 9606
267 4K23 1 H anti-uPAR antibody, heavy chain 10090
268 4K23 2 L anti-uPAR antibody, light chain 10090
269 3NCJ 1 L Fab15 Mut8 light chain 9606
270 3NCJ 2 H Fab15 Mut8 heavy chain 9606
271 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
272 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
273 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
274 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
275 5W05 1 L M59 FAB LIGHT CHAIN 10090
276 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
277 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
278 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
279 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
280 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
281 4M61 1 A, C Fab A52 light chain 10090
282 4M61 2 B, D Fab A52 heavy chain 10090
283 5YE3 1 B 2A7D9 VH CH1 chain 10090
284 5YE3 2 A 2A7D9 L chain 10090
285 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
286 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
287 1UM5 1 L Antibody 21H3 L chain 10090
288 1UM5 2 H Antibody 21H3 H chain 10090
289 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
290 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
291 4NWT 1 L APE1531 Ab Fab light chain 9606
292 4NWT 2 H APE1531 Ab Fab heavy chain 9606
293 3WHX 1 A mAb Fab H fragment 10090
294 3WHX 2 B mAb Fab L fragment 10090
295 3NA9 1 L Fab15 light chain 9606
296 3NA9 2 H Fab15 heavy chain 9606
297 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
298 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
299 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
300 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
301 4LRI 1 A, B MSL-109 Light Chain 9606
302 4LRI 2 C, P MSL-109 Heavy Chain 9606
303 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
304 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
305 4JN2 1 A, L anti dabigatran Fab 10090
306 4JN2 2 B, H anti dabigatran Fab 10090
307 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
308 4XBE 2 H 4E10 Fab heavy chain 9606
309 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
310 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
311 6BE2 1 H Fab (F598) Heavy Chain 9606
312 6BE2 2 L Fab (F598) Light Chain 9606
313 4JFZ 1 L Fab light chain 9606
314 4JFZ 2 H Fab heavy chain 9606
315 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
316 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
317 3WIF 1 A mAb Fab H fragment 10090
318 3WIF 2 B mAb Fab L fragment 10090
319 5U6A 1 A Light Chain 9606
320 5U6A 2 B Heavy Chain 9606
321 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
322 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
323 3MBX 1 L X836 LIGHT CHAIN 10090
324 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
325 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
326 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
327 6APC 1 H Epididymis luminal protein 214 9606
328 6APC 2 L IGL@ protein 9606
329 4HHA 1 A Fab KE5 Fab fragment KE5 9606
330 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
331 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
332 4RGO 2 H 14G8 heavy chain Fab 10090
333 4RGO 3 L 14G8 light chain Fab 10090
334 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
335 5GRY 1 A, G diabody 9606
336 5UEK 2 H Fab 12E Heavy Chain 9606
337 5UEK 3 L Fab 12E Light Chain 9606
338 3NAA 1 L Fab15 Mut5 light chain 9606
339 3NAA 2 H Fab15 Mut5 heavy chain 9606
340 1Q0X 1 L Fab 9B1, light chain 10090
341 1Q0X 2 H Fab 9B1, heavy chain 10090
342 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
343 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
344 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
345 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
346 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
347 5IK3 2 B, D 1E03 Fab fragment light chain 9606
348 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
349 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
350 5XLI 1 a, b FabL 10090
351 5XLI 2 c, d FabH 10090
352 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
353 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
354 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
355 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
356 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
357 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
358 4WUK 1 H CH65 heavy chain 9606
359 4WUK 2 L CH65 light chain 9606
360 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
361 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
362 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
363 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
364 5JOP 1 D, L Fab 14.22 light chain 10090
365 5JOP 2 E, H Fab14.22 heavy chain 10090
366 4HPO 1 H CH58 Fab heavy chain 9606
367 4HPO 2 L CH58 Fab light chain 9606
368 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
369 5UKN 2 L DH522UCA Fab fragment light chain 9544
370 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
371 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
372 5IT2 1 H heavy chain 9606
373 5IT2 2 L light chain 9606
374 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
375 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
376 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
377 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
378 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
379 5MO3 3 L Fab of monoclonal antibody, light chain 10090
380 5GZ0 1 A, C FM329 light chain 1383439
381 5GZ0 2 B, D FM329 heavy chain 1383439
382 6DW2 1 A 6078 Fab light chain 9606
383 6DW2 2 B 6078 Fab heavy chain 9606
384 6BQB 1 L MGG4 Fab light chain 9606
385 6BQB 2 H MGG4 Fab heavy chain 9606
386 4PUB 1 H DX-2930 HEAVY CHAIN 9606
387 4PUB 2 L DX-2930 LIGHT CHAIN 9606
388 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
389 6B14 2 L Light chain of Fab BL3-6S97N 10090
390 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
391 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
392 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
393 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
394 5GS3 1 A, H diabody protein 9606
395 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
396 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
397 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
398 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
399 5VKD 2 H Fab Heavy Chain 9606
400 5VKD 3 L Fab light chain 9606
401 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
402 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
403 5XHG 1 A, C polypeptide(L) 10090
404 5XHG 2 B, D polypeptide(H) 10090
405 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
406 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
407 3UYR 1 H antibody Fab heavy chain 10090
408 3UYR 2 L antibody Fab light chain 10090
409 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
410 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
411 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
412 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
413 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
414 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
415 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
416 3OAZ 2 K, L Fab 2G12, light chain 9606
417 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
418 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
419 1ZAN 1 L Fab AD11 Light Chain 10116
420 1ZAN 2 H Fab AD11 Heavy Chain 10116
421 6CJK 1 A, C Immunoglobulin Fab light chain 9986
422 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
423 4N0Y 1 H IGH526 Heavy Chain 9606
424 4N0Y 2 L IGH526 Light Chain 9606
425 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
426 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
427 5MTH 1 A, H antibody Fab heavy chain 10090
428 5MTH 2 B, L antibody Fab light chain 10090
429 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
430 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
431 1RZF 1 L Fab E51 light chain 9606
432 1RZF 2 H Fab E51 heavy chain 9606
433 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
434 4KTE 2 L GE148 Light Chain Fab 9544
435 5I8O 1 H HMM5 antibody heavy chain 9606
436 5I8O 2 L HMM5 antibody light chain 9606
437 4JG0 1 L Fab light chain 9606
438 4JG0 2 H Fab heavy chain 9606
439 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
440 4YGV 2 B, L aDabi-Fab2a light chain 9606
441 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
442 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
443 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
444 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
445 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
446 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
447 3EO0 1 A, C GC-1008 Fab Light Chain 10090
448 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
449 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
450 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
451 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
452 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
453 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
454 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
455 4FQI 3 H antibody CR9114 heavy chain Fab 9606
456 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
457 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
458 4JHA 2 L D25 light chain 9606
459 6B9Z 1 A Trastuzumab Fab light chain 10090
460 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
461 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
462 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
463 4PTT 1 A Antibody pn132p2C05, light chain 9606
464 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
465 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
466 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
467 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
468 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
469 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
470 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
471 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
472 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
473 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
474 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
475 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
476 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
477 4DGV 1 H HCV1 Heavy Chain Fab 9606
478 4DGV 2 L HCV1 Light Chain 9606
479 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
480 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
481 5TH2 1 A, C cetuximab Fab, light chain 10090
482 5TH2 2 B, D cetuximab Fab, heavy chain 10090
483 5I8K 1 L HHH1 Fab Light chain 9606
484 5I8K 2 H HHH1 Fab Heavy chain 9606
485 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
486 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
487 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
488 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
489 1YNL 1 L Ig gamma light chain 10090
490 1YNL 2 H Ig gamma heavy chain 10090
491 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
492 5EPM 2 B, F Antibody Fab fragment light chain 10090
493 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
494 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
495 3UMT 1 A scFv heavy chain and light chain 10090
496 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
497 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
498 4NUJ 1 A PGT152 light chain 9606
499 4NUJ 2 B PGT152 heavy chain 9606
500 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
501 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
502 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
503 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
504 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
505 3U2S 2 B, L PG9 light chain 9606
506 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
507 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
508 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
509 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
510 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
511 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
512 4NUG 1 L PGT151 light chain 9606
513 4NUG 2 H PGT151 heavy chain 9606
514 3IU4 1 H chP3 Fab heavy chain 10090
515 3IU4 2 L chP3 Fab light chain 10090
516 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
517 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
518 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
519 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
520 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
521 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
522 1P7K 1 A, L antibody light chain FAB 10090
523 1P7K 2 B, H antibody heavy chain FAB 10090
524 3RVV 2 C 4C1 - light chain 10090
525 3RVV 3 D 4C1 - heavy chain 10090
526 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
527 3P0Y 2 H Fab DL11 heavy chain 9606
528 3P0Y 3 L Fab DL11 light chain 9606
529 4NPY 1 A, L germline PGT121 light chain Fab 9606
530 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
531 6ANA 2 H LL2 Fab Heavy Chain 10090
532 6ANA 3 L LL2 Fab Light Chain 10090
533 5IBU 1 B, L 6652 Light Chain 9606
534 5IBU 2 G, H 6652 Heavy Chain 9606
535 5VPL 2 C 4C1 - LIGHT CHAIN 10090
536 5VPL 3 D 4C1 - HEAVY CHAIN 10090
537 6AOD 1 A FXIa Antibody FAB Light Chain 9606
538 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
539 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
540 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
541 2YPV 2 H FAB 12C1 10090
542 2YPV 3 L FAB 12C1 10090
543 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
544 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
545 4JY5 1 L PGT122 light chain Fab 9606
546 4JY5 2 H PGT122 heavy chain Fab 9606
547 6ELE 1 A, H fAB heavy chain 9606
548 6ELE 2 B, L fAB light chain 9606
549 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
550 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
551 6B5R 1 H CIS42 Fab Heavy chain 9606
552 6B5R 2 L CIS42 Fab Light chain 9606
553 3NAC 1 L Fab15 Mut7 light chain 9606
554 3NAC 2 H Fab15 Mut7 heavy chain 9606
555 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
556 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
557 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
558 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
559 1Q72 1 L Fab M82G2, Light chain 10090
560 1Q72 2 H Fab M82G2, Heavy chain 10090
561 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
562 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
563 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
564 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
565 4YHO 1 H aDabi-Fab3 heavy chain 9606
566 4YHO 2 L aDabi-Fab3 light chain 9606
567 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
568 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
569 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
570 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
571 4DGY 1 H HCV1 Heavy Chain Fab 9606
572 4DGY 2 L HCV1 Light Chain 9606
573 5EN2 1 A GD01 heavy chain 10090
574 5EN2 2 B GD01 light chain 10090
575 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
576 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
577 3MXW 2 L 5E1 light chain 9606
578 3MXW 3 H 5E1 heavy chain 9606
579 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
580 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
581 3EO9 1 L Efalizumab Fab fragment, light chain 9606
582 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
583 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
584 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
585 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
586 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
587 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
588 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
589 5WUV 1 L light chain 9606
590 5WUV 2 H heavy chain 9606
591 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
592 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
593 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
594 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
595 4JM4 1 H PGT 135 Heavy Chain Fab 9606
596 4JM4 2 L PGT 135 Light Chain Fab 9606
597 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
598 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
599 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
600 5YE4 2 B, D 1A9D7 L chain 10090
601 6B0G 1 C 1245 Antibody, Light Chain 9606
602 6B0G 2 D 1245 Antibody, Heavy Chain 9606
603 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
604 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
605 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
606 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
607 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
608 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
609 6D0X 1 A 2140 Antibody, heavy chain 9606
610 6D0X 2 B 1210 Antibody, light chain 9606
611 6BE4 1 H Fab (F598) Heavy Chain 9606
612 6BE4 2 L Fab(F598) Light Chain 9606
613 5TPP 1 L DH270.5 Fab heavy chain 9606
614 5TPP 2 H DH270.5 Fab light chain 9606
615 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
616 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
617 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
618 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
619 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
620 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
621 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
622 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
623 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
624 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
625 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
626 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
627 5TL5 1 L M2177 LIGHT CHAIN 10090
628 5TL5 2 H M2177 HEAVY CHAIN 10090
629 2FX7 1 L Fab 4E10 Light Chain 9606
630 2FX7 2 H Fab 4E10 Heavy Chain 9606
631 5Y9K 1 L belimumab light chain 9606
632 5Y9K 2 H belimumab heavy chain 9606
633 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
634 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
635 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
636 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
637 3WFH 1 A mAb Fab H fragment 10090
638 3WFH 2 B mAb Fab L fragment 10090
639 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
640 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
641 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
642 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
643 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
644 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
645 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
646 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
647 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
648 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
649 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
650 5HI4 3 D, L CAT-2000 FAB light chain 9606
651 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
652 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
653 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
654 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
655 3RVW 2 C 4C1 - light chain 10090
656 3RVW 3 D 4C1 - heavy chain 10090
657 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
658 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
659 5XKU 2 B HNIgGA6 light chain 9606
660 5XKU 3 C HNIgGA6 heavy chain 9606
661 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
662 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
663 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
664 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
665 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
666 5HI5 3 D, L CAT-2000 light chain 9606
667 5JO5 1 A, C, E, H 10E8 gHV 9606
668 5JO5 2 B, D, F, L 10E8 gLV 9606
669 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
670 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
671 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
672 5CCK 2 L Antibody 3BC315 Fab light chain 9606
673 5I76 1 A, C FM318_light_chain 1383439
674 5I76 2 B, D FM318_heavy_cahin 1383439
675 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
676 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
677 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
678 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
679 5I18 1 L FAB LIGHT CHAIN 9606
680 5I18 2 H FAB HEAVY CHAIN 9606
681 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
682 4JN1 2 L anti-dabigatran Fab1, light chain 10090
683 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
684 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
685 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
686 4G5Z 2 L canakinumab antibody fragment light chain 9606
687 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
688 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
689 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
690 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
691 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
692 2OK0 2 L Fab ED10 light chain 10090
693 2OK0 3 H Fab ED10 heavy chain 10090
694 3SOB 1 L antibody light chain 9606
695 3SOB 3 H antibody heavy chain 9606
696 6B5M 1 H CIS43 Fab Heavy chain 9606
697 6B5M 2 L CIS43 Fab Light chain 9606
698 5AWN 1 H Heavy chain of 3BC176 Fab 9606
699 5AWN 2 L Light chain of 3BC176 Fab 9606
700 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
701 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
702 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
703 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
704 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
705 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
706 5DR5 2 L AbD09097 Fab light chain 9606
707 2IH3 1 A FAB Heavy Chain 10090
708 2IH3 2 B FAB Light Chain 10090
709 4KQ3 1 L CNTO3186 light chain Fab 9606
710 4KQ3 2 H CNTO3186 heavy chain Fab 9606
711 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
712 6AQ7 3 L POM6 FAB light CHAIN 10090
713 4JFX 1 A, L Fab light chain 9606
714 4JFX 2 B, H Fab heavy chain 9606
715 3SGE 1 I, L Light Chain 10090
716 3SGE 2 H, J Heavy Chain 10090
717 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
718 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
719 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
720 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
721 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
722 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
723 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
724 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
725 5FHB 1 H Antibody 100 Fab heavy chain 9606
726 5FHB 2 L Antibody 100 Fab light chain 9606
727 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
728 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
729 1JGU 1 L Antibody Light Chain 10090
730 1JGU 2 H Antibody Heavy Chain 10090
731 4I77 1 H Lebrikizumab heavy chain Fab 9606
732 4I77 2 L Lebrikizumab light chain Fab 9606
733 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
734 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
735 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
736 4O4Y 2 H 2095-2 heavy chain 9986
737 5OBF 1 H fAb Heavy chain 10090
738 5OBF 2 L fAb Light chain 10090
739 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
740 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
741 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
742 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
743 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
744 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
745 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
746 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
747 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
748 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
749 5MHE 1 L Fab-fragment 10090
750 5MHE 2 H Fab-fragment 10090
751 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
752 4GLR 3 I, K anti-ptau light chain light chain 9031
753 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
754 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
755 4HJG 1 A Trastuzumab light chain 9606
756 4HJG 2 B Trastuzumab heavy chain 9606
757 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
758 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
759 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
760 5I30 1 L Fab PL-2 light chain 10090
761 5I30 2 H Fab PL-2 heavy chain 10090
762 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
763 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
764 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
765 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
766 3FN0 1 L Fab Z13e1 light chain 9606
767 3FN0 2 H Fab Z13e1 heavy chain 9606
768 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
769 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
770 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
771 4YHI 2 B, L aDabi-Fab2a light chain 9606
772 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
773 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
774 4OSU 1 H SM5-1 Fab Heavy Chain 9606
775 4OSU 2 L SM5-1 Fab Light Chain 9606
776 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
777 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
778 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
779 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
780 1T2Q 1 L Fab NNA7 Heavy Chain 10090
781 1T2Q 2 H Fab NNA7 Light Chain 10090
782 6ELJ 1 A, H fAB heavy chain 9606
783 6ELJ 2 B, L fAB light chain 9606
784 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
785 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
786 4MAU 1 L C2244 light chain SEE REMARK 999 10090
787 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
788 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
789 3LEX 2 B, L 11f10 Antibody Light Chain 10090
790 6B0W 1 L 1710 antibody, light chain 9606
791 6B0W 2 H 1710 antibody, heavy chain 9606
792 1OP3 1 K, L FAB 2G12, light chain light chain 9606
793 1OP3 2 H, M FAB 2G12, heavy chain heavy chain 9606
794 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
795 5VH4 2 B, L Infliximab Fab Light Chain 10090
796 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
797 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
798 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
799 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
800 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
801 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
802 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
803 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
804 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
805 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
806 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
807 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
808 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
809 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
810 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
811 3S96 1 A, C 3B5H10 FAB heavy chain 10090
812 3S96 2 B, D 3B5H10 FAB light chain 10090
813 4LKX 1 A Fab fragment heavy chain 9606
814 4LKX 2 B Fab fragment light chain 9606
815 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
816 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
817 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606
818 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606
819 5JW5 1 A, H MEDI8852 Heavy chain 9606
820 5JW5 2 B, L MEDI8852 Light chain 9606
821 5VH3 1 A, H Infliximab Fab Heavy Chain 10090
822 5VH3 2 B, L Infliximab Fab Light Chain 10090
823 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
824 6DCV 2 B, H heavy chain of CBTAU-27.1 Fab 9606
825 5HDQ 2 H Fab Heavy Chain 10090
826 5HDQ 3 L Fab Light Chain 10090
827 4FQ2 1 H Fab heavy chain 9606
828 4FQ2 2 L Fab light chain 9606
829 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090
830 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090
831 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090
832 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090
833 2A77 1 L Immunoglobulin Light Chain 10090
834 2A77 2 H Immunoglobulin Heavy Chain 10090
835 2FB4 1 L IGG1-LAMBDA KOL FAB (LIGHT CHAIN) 9606
836 2FB4 2 H IGG1-LAMBDA KOL FAB (HEAVY CHAIN) 9606
837 3GO1 1 L Fab 268-D, light chain 9606
838 3GO1 2 H Fab 268-D, heavy chain 9606
839 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090
840 1F3D 2 H, K CATALYTIC ANTIBODY 4B2 HEAVY CHAIN - FAB FRAGMENT 10090
841 3QWO 1 B, L motavizumab light chain 10090
842 3QWO 2 A, H motavizumab heavy chain 10090
843 3CVI 1 H 25-D1.16 Heavy chain 10090
844 3CVI 2 L 25-D1.16 Light chain 10090
845 1PZ5 1 A Light chain of Fab (SYA/J6) 10090
846 1PZ5 2 B Heavy chain of Fab (SYA/J6) 10090
847 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116
848 1LK3 3 H, I 9D7 Heavy Chain Fab fragment, Residues 1-219 10116
849 4IOI 1 A Trastuzumab light chain 9606
850 4IOI 2 B Trastuzumab heavy chain 9606
851 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090
852 1N7M 2 L Germline Metal Chelatase Catalytic Antibody, chain L 10090
853 4OKV 1 A, C heavy chain of 8H7 mAb 10090
854 4OKV 2 B, D light chain of 8H7 mAb 10090
855 6GHG 1 A, H Fab heavy chain 9606
856 6GHG 2 B, L Fab light chain 9606
857 6B5S 1 H CIS42 Fab Heavy chain 9606
858 6B5S 2 L CIS42 Fab Light chain 9606
859 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
860 5K8A 2 B, F, H, V Heavy chain 10090
861 5WKZ 1 H Immunoglobulin heavy variable 1-69D,IgG H chain 9606
862 5WKZ 2 L Lambda-chain (AA -20 to 215) 9606
863 1JGV 1 L Antibody Light Chain 10090
864 1JGV 2 H Antibody Heavy Chain 10090
865 5VAG 2 B Light chain of antibody m826 9606
866 5VAG 3 C Heavy chain of antibody m826 9606
867 3MLX 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
868 3MLX 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
869 3I9G 1 H Sonepcizumab antibody Fab fragment, heavy chain Fab Fragment 10090
870 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090
871 5GIR 1 A, H Heavy chain of Fab fragment 10090
872 5GIR 2 B, L Light chain of Fab fragment 10090
873 2ADF 2 H 82D6A3 IgG FAB 10090
874 2ADF 3 L 82D6A3 IgG FAB 10090
875 5I16 1 A, L FAB LIGHT CHAIN 9606
876 5I16 2 B, H FAB HEAVY CHAIN 9606
877 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090
878 3O41 2 A, H Mouse monoclonal antibody 101F Fab heavy chain 10090
879 5F9O 2 H CH235.9 Heavy chain 9606
880 5F9O 3 L CH235.09 Light chain 9606
881 3Q6G 1 L, M Light chain of Fab of rhesus mAb 2.5B 9544
882 3Q6G 2 H, I Heavy chain of Fab of rhesus mAb 2.5B 9544
883 1UM4 1 L Antibody 21H3 L chain 10090
884 1UM4 2 H Antibody 21H3 H chain 10090
885 5VJQ 1 A, C, E, G HyHEL10 heavy chain Fab fragment carrying three mutations; I29F, S52T, Y53F DEL-I 10090 3.2.1.18 | Details
886 5VJQ 2 B, D, F, H HyHEL10 light chain Fab fragment 10090
887 4RBP 1 K, L Fab 2G12 light chain 9606
888 4RBP 2 H, M Fab 2G12 heavy chain 9606
889 3I75 1 A Antibody heavy chain 10090
890 3I75 2 B Antibody light chain 10090
891 4XVS 1 H VRC07_1995 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Heavy chain 9606
892 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606
893 7FAB 1 L IGG1-LAMBDA NEW FAB (LIGHT CHAIN) 9606
894 7FAB 2 H IGG1-LAMBDA NEW FAB (HEAVY CHAIN) 9606
895 4FQL 1 H monoclonal antibody CR8033 heavy chain Fab 9606
896 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606
897 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
898 1NGX 2 B, H Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
899 1E6O 1 H IMMUNOGLOBULIN HEAVY CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') HEAVY CHAIN 1-219 10090
900 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090
901 5GIS 1 H Heavy chain of Fab fragment 10090
902 5GIS 2 L Light chain of Fab fragment 10090
903 1JFQ 1 L ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY LIGHT CHAIN 10090
904 1JFQ 2 H ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY HEAVY CHAIN 10090
905 6B0S 1 H 1710 antibody, heavy chain 9606
906 6B0S 2 L 1710 antibody, light chain 9606
907 5FGC 2 B Anti-HCV E2 Fab HC33.8 light chain 9606
908 5FGC 3 E Anti-HCV E2 Fab HC33.8 heavy chain 9606
909 5GRX 1 G, H diabody protein 9606
910 6DCW 1 L Light chain of CBTAU27.1 Fab 9606
911 6DCW 2 H Heavy chain of CBTAU27.1 Fab 9606
912 6DB6 1 H Human monoclonal anti-HIV-1 gp120 V3 antibody 311-11D Fab heavy chain 9606
913 6DB6 2 L Human monoclonal anti-HIV-1 gp120 V3 antibody 311-11D Fab light chain 9606
914 4H20 1 L Light chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
915 4H20 2 H Heavy chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
916 5GGQ 1 L nivolumab light chain 9606
917 5GGQ 2 H nivolumab heavy chain 9606
918 4RFE 1 A, C, E, H Fab heavy chain of ADCC-potent anti-HIV-1 antibody JR4 9544
919 4RFE 2 B, D, F, L Fab light chain of ADCC-potent anti-HIV-1 antibody JR4 9544
920 6B5N 1 H CIS43 Fab Heavy chain 9606
921 6B5N 2 L CIS43 Fab Light chain 9606
922 3OAY 1 K, L Fab 2G12, light chain 9606
923 3OAY 2 H, M Fab 2G12, heavy chain 9606
924 1CR9 1 L FAB ANTIBODY LIGHT CHAIN HEAVY CHAIN 10090
925 1CR9 2 H FAB ANTIBODY HEAVY CHAIN LIGHT CHAIN 10090
926 6AND 2 H Pinatuzumab Fab Heavy chain 9606
927 6AND 3 L Pinatuzumab Fab light chain 9606
928 1A3L 1 L IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090
929 1A3L 2 H IMMUNOGLOBULIN FAB 13G5 (HEAVY CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090
930 5W0D 2 B Lineage K03.12 UCA antibody heavy chain 9606
931 5W0D 3 C Lineage K03.12 UCA antibody light chain 9606
932 1YEJ 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090
933 1YEJ 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING FRAGMENT 10090
934 4GMT 1 L, M Fab S139/1 light chain 10090
935 4GMT 2 H, I Fab S139/1 heavy chain 10090
936 6BPB 1 A Monoclonal antibody 4F7 Fab heavy chain 10090
937 6BPB 2 B Monoclonal antibody 4F7 Fab light chain 10090
938 5K9J 1 H 56.a.09 heavy chain 9606
939 5K9J 2 L 56.a.09 light chain 9606
940